Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Dexcom (DXCM)
NASDAQ:DXCM
Dexcom (DXCM) Stock Price & Analysis
2,447 Followers
DXCM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$66.89 - $134.77
Previous Close$118.98
Volume216.41K
Average Volume (3M)2.51M
Market Cap
$45.57B
Enterprise Value$45.66B
Total Cash (Recent Filing)$2.46B
Total Debt (Recent Filing)$2.15B
Price to Earnings (P/E)145.5
Beta1.35
Next Earnings
May 03, 2023EPS Estimate
$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.82
Shares Outstanding386,413,690
10 Day Avg. Volume2,644,445
30 Day Avg. Volume2,512,200
Standard Deviation0.16
R-Squared0.14
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)22.94
Price to Sales (P/S)15.24
Price to Cash Flow (P/CF)73.30
P/FCF Ratio147.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue15.69
Enterprise Value/Gross Profit24.25
Enterprise Value/Ebitda80.66
Forecast
1Y Price Target
$130.25Price Target Upside10.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Dexcom News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DXCM FAQ
What was Dexcom’s price range in the past 12 months?
Dexcom lowest stock price was $66.89 and its highest was $134.76 in the past 12 months.
What is Dexcom’s market cap?
Currently, no data Available
When is Dexcom’s upcoming earnings report date?
Dexcom’s upcoming earnings report date is May 03, 2023 which is in 42 days.
How were Dexcom’s earnings last quarter?
Dexcom released its earnings results on Feb 09, 2023. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.273 by $0.067.
Is Dexcom overvalued?
According to Wall Street analysts Dexcom’s price is currently Undervalued.
Does Dexcom pay dividends?
Dexcom does not currently pay dividends.
What is Dexcom’s EPS estimate?
Dexcom’s EPS estimate is $0.15.
How many shares outstanding does Dexcom have?
Dexcom has 386,413,700 shares outstanding.
What happened to Dexcom’s price movement after its last earnings report?
Dexcom reported an EPS of $0.34 in its last earnings report, beating expectations of $0.273. Following the earnings report the stock price went up 9.931%.
Which hedge fund is a major shareholder of Dexcom?
Among the largest hedge funds holding Dexcom’s share is Sands Capital Management LLC. It holds Dexcom’s shares valued at 2B.
---
Dexcom Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$130.25 (10.46% Upside)
$130.25 (10.46% Upside)
Blogger Sentiment
Bullish
DXCM Sentiment 83%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 1.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.38%
12-Months-Change
Fundamentals
Return on Equity
15.57%
Trailing 12-Months
Asset Growth
10.86%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Dexcom
California-based DexCom, Inc. is a medical device manufacturing company. The company designs, develops and focuses on commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes. Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share.
---
Intuitive Surgical
―
Stryker
―
Becton Dickinson
―
Boston Scientific
―
Edwards Lifesciences
―
---